Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Rulan Griesel"'
Autor:
Pranav Rajpurkar, Chloe O’Connell, Amit Schechter, Nishit Asnani, Jason Li, Amirhossein Kiani, Robyn L. Ball, Marc Mendelson, Gary Maartens, Daniël J. van Hoving, Rulan Griesel, Andrew Y. Ng, Tom H. Boyles, Matthew P. Lungren
Publikováno v:
npj Digital Medicine, Vol 3, Iss 1, Pp 1-8 (2020)
Abstract Tuberculosis (TB) is the leading cause of preventable death in HIV-positive patients, and yet often remains undiagnosed and untreated. Chest x-ray is often used to assist in diagnosis, yet this presents additional challenges due to atypical
Externí odkaz:
https://doaj.org/article/7e39bc9219eb4fc4b15d71d68221dc99
Autor:
Zimasa Gcwabe, Kaneez Sayed, Charlotte Schutz, Olina Ngwenya, Eric Goemaere, Rene Goliath, Amanda Jackson, Rulan Griesel, Andrew Hill, Graeme Meintjes, Tali Cassidy, Claire Keene, Ying Zhao, Gary Maartens
Publikováno v:
Wellcome Open Research, Vol 6 (2021)
Background: Dolutegravir has superior efficacy and tolerability than lopinavir-ritonavir in second-line antiretroviral therapy after failure of a first-line non-nucleoside reverse transcriptase inhibitors-based regimen, when dolutegravir is accompani
Externí odkaz:
https://doaj.org/article/e8ddb6039ab343c6b5eeeafa3cbc416f
Publikováno v:
Wellcome Open Research, Vol 6 (2021)
Dolutegravir, a second-generation integrase strand transfer inhibitor (InSTI), is replacing efavirenz as first-line antiretroviral therapy (ART) in low middle-income countries (LMICs). Tuberculosis remains the leading cause of HIV-related morbidity a
Externí odkaz:
https://doaj.org/article/358ecaf3694a4af28899fe534ecf6f2e
Publikováno v:
International Journal of Infectious Diseases, Vol 75, Iss , Pp 67-73 (2018)
Background: Tuberculosis is a major cause of mortality among HIV-infected inpatients, and the World Health Organization (WHO) recommends an algorithm to improve diagnosis. The urine lateral flow lipoarabinomannan (LAM) and sputum Xpert MTB/RIF tests
Externí odkaz:
https://doaj.org/article/079c67ae002448a29cd77f64d1307a26
Autor:
Fiona Mendelson, Rulan Griesel, Nicki Tiffin, Molebogeng Rangaka, Andrew Boulle, Marc Mendelson, Gary Maartens
Publikováno v:
BMC Infectious Diseases, Vol 18, Iss 1, Pp 1-11 (2018)
Abstract Background Tuberculosis, bacterial community-acquired pneumonia (CAP), and Pneumocystis jirovecii pneumonia (PJP) are the three commonest causes of hospitalisation in HIV-infected adults. Prompt diagnosis and treatment initiation are importa
Externí odkaz:
https://doaj.org/article/9cc0e124f48c411b98e9231aee2f6c01
Autor:
Rulan Griesel, Annemie Stewart, Helen van der Plas, Welile Sikhondze, Marc Mendelson, Gary Maartens
Publikováno v:
AIDS Research and Therapy, Vol 15, Iss 1, Pp 1-9 (2018)
Abstract Background Criteria for the 2007 WHO algorithm for diagnosing tuberculosis among HIV-infected seriously ill patients are the presence of one or more danger signs (respiratory rate > 30/min, heart rate > 120/min, temperature > 39 °C, and bei
Externí odkaz:
https://doaj.org/article/56dbbc859eff45c095119a6f9b9ccff5
Autor:
Gary Maartens, Annemie Stewart, Rulan Griesel, Andre P. Kengne, Felix Dube, Mark Nicol, Molebogeng X. Rangaka, Marc Mendelson
Publikováno v:
Southern African Journal of HIV Medicine, Vol 19, Iss 1, Pp e1-e6 (2018)
Background: The World Health Organization (WHO) algorithm for the diagnosis of tuberculosis in seriously ill HIV-infected patients recommends that treatment for Pneumocystis jiroveciipneumonia (PJP) should be considered without giving clear guidance
Externí odkaz:
https://doaj.org/article/9e08131925814b26b704eab77ed9796c
Autor:
Claire M. Keene, Tali Cassidy, Ying Zhao, Rulan Griesel, Amanda Jackson, Kaneez Sayed, Zaayid Omar, Andrew Hill, Olina Ngwenya, Gert Van Zyl, Tracy Flowers, Eric Goemaere, Gary Maartens, Graeme Meintjes
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 92:422-429
Autor:
Ying Zhao, Rulan Griesel, Zaayid Omar, Bryony Simmons, Andrew Hill, Gert van Zyl, Claire Keene, Gary Maartens, Graeme Meintjes
Publikováno v:
Clinical Infectious Diseases. 76:1832-1840
Background Dolutegravir concentrations are reduced by efavirenz induction effect necessitating twice-daily dolutegravir dosing when coadministered. Efavirenz induction persists for several weeks after stopping, which could potentially select for dolu
Autor:
Rulan Griesel, Ying Zhao, Bryony Simmons, Zaayid Omar, Lubbe Wiesner, Claire M Keene, Andrew M Hill, Graeme Meintjes, Gary Maartens
Publikováno v:
The Lancet HIV.